Skip to main content
All lobbying filings

LMH Strategic Solutions

LMH Strategic Solutions filed a Q4 report for Ionis Pharmaceuticals, Inc. on January 12, 2026, reporting $60,000 in lobbying income.

Lobbying for Ionis Pharmaceuticals, Inc. · Biotechnology company.

As filed: LMH STRATEGIC SOLUTIONS for IONIS PHARMACEUTICALS, INC.

All filings by LMH Strategic Solutions · Everything Ionis Pharmaceuticals, Inc. has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 12, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Lobbyists on this filing 1
  • ALANNA TEMME
    Previously held: Legislative Director, U.S. Representative Jon Porter

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Pediatric Review Reauthorization. H.R.946/S.1862 - ORPHAN Cures Act. H.R.1672 - Maintaining Investments in New Innovation (MINI) Act. H.R.1262/S.932 - Give Kids a Chance Act of 2025.

 Bills named in this filing 5

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem